Literature DB >> 10530460

Novelties in the field of anti-infectives in 1998.

A Bryskier1.   

Abstract

In 1998, about 30 new medicinal chemical entities in the field of antibacterials and antifungals were presented during the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, held in San Diego. Among these compounds, only a few of them seem to be candidates for preclinical and clinical development: GAR 936, RWJ 54,418, ME 1209, L-084, FK 483, and DC 756. Other compounds seem to be in the preselection stage or potential lead compounds.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10530460     DOI: 10.1086/598646

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  3 in total

1.  Comparative in vitro activities of GAR-936 against aerobic and anaerobic animal and human bite wound pathogens.

Authors:  E J Goldstein; D M Citron; C V Merriam; Y Warren; K Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

2.  Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936).

Authors:  Takahiro Hirata; Asami Saito; Kunihiko Nishino; Norihisa Tamura; Akihito Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

Review 3.  Quinolone antibiotics.

Authors:  Thu D M Pham; Zyta M Ziora; Mark A T Blaskovich
Journal:  Medchemcomm       Date:  2019-06-28       Impact factor: 3.597

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.